|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/352 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2710137 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12755115.8 |
| Europos patento paraiškos padavimo data | 2012-03-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-03-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/028412 |
| Data | 2012-03-09 |
| (87) | Numeris | WO 2012/122444 |
| Data | 2012-09-13 |
| (30) | Numeris | Data | Šalis |
| 201161451395 P | 2011-03-10 | US |
| (72) |
EAGLE, Craig J., US
DEES, H. Craig, US
WACHTER, Eric A., US
SINGER, Jamie, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
Provectus Pharmatech, Inc., 10025 Investment Drive, Suite 250, Knoxville, Tennessee 37932, US |
| (54) | A COMBINATION OF ROSE BENGAL AND ANTI-CTLA4 ANTIBODY FOR USE IN THE TREATMENT OF CANCER |
| A COMBINATION OF ROSE BENGAL AND ANTI-CTLA4 ANTIBODY FOR USE IN THE TREATMENT OF CANCER |